ARTICLE | Company News
Hauser Chemical Research Inc. other research news
October 11, 1993 7:00 AM UTC
The company received a $500,000 Phase II SBIR grant from the National Institute of Allergy and Infectious Diseases to develop artemisinin derivatives to treat opportunistic parasitic infections in imm...